NEW YORK (GenomeWeb News) – GE Healthcare said this week it won a tender offer to exclusively provide next-generation sequencing services to a Karolinksa Institutet research group. The first clinical study using the technology will be directed at identifying mutations and genetic variants associated with metastatic breast cancer. Karolinska will provide patient tissue samples for the study. SeqWright Genomics Services, a subsidiary of GE Healthcare, will provide the sequencing services for analysis of the tissue samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.